ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,039Medicare Part D Prescriptions Filled, Including Refills

Rank: 121 out of 1456

$1.18M Total Retail Price of All Prescriptions

Rank: 73 out of 1456

679 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 679 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

18% of this provider’s 679 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 14,573 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 833 661 1 2
HYDROCODONE-ACETAMINOPHEN 574 430 S3 2 6
OMEPRAZOLE 503 390 3 5
LISINOPRIL 468 401 4 3
LEVOTHYROXINE SODIUM 423 346 5 4
FUROSEMIDE 405 332 6 7
METFORMIN HCL 392 312 7 8
AMLODIPINE BESYLATE 382 307 8 1
ZOLPIDEM TARTRATE 322 259 9 14
LOSARTAN POTASSIUM 320 253 10 16
WARFARIN SODIUM 301 233 11 21
METOPROLOL TARTRATE 300 247 12 12
BYSTOLIC 293 265 13 102
PRAVASTATIN SODIUM 290 276 14 9
POTASSIUM CHLORIDE 289 250 15 15
METOPROLOL SUCCINATE 248 221 16 19
RANITIDINE HCL 238 188 17 27
ALLOPURINOL 209 182 18 31
TRAMADOL HCL 199 140 19 17
NEXIUM 196 140 20 23
NAMENDA 190 179 21 38
DONEPEZIL HCL 188 188 22 29
CARVEDILOL 186 156 23 20
SERTRALINE HCL 186 134 23 25
PREDNISONE 172 112 25 42
CITALOPRAM HBR 167 142 26 22
GABAPENTIN 167 90 26 13
CYCLOBENZAPRINE HCL 152 103 R 28 66
CIPROFLOXACIN HCL 136 119 29 58
PANTOPRAZOLE SODIUM 133 104 30 43
MELOXICAM 133 80 30 30
DIOVAN 131 107 32 35
ATORVASTATIN CALCIUM 130 114 33 11
TAMSULOSIN HCL 126 122 34 34
PAROXETINE HCL 119 72 35 67
CLOPIDOGREL 116 113 36 32
QUINAPRIL HCL 116 103 36 155
FLUOXETINE HCL 112 87 38 55
SYNTHROID 112 108 38 37
BENICAR 111 111 40 130
HYDROCHLOROTHIAZIDE 111 88 40 10
GLIMEPIRIDE 109 104 42 33
LOSARTAN-HYDROCHLOROTHIAZIDE 106 95 43 41
FENTANYL 102 93 S2 44 114
CELEBREX 99 97 45 88
ESCITALOPRAM OXALATE 99 72 45 74
INSULIN SYRINGE 99 70 45 64
FLUTICASONE PROPIONATE 96 82 48 28
LANTUS 93 89 49 50
RAMIPRIL 92 69 50 98
CRESTOR 90 71 51 26
BENICAR HCT 85 79 52 160
CYMBALTA 83 76 53 52
PLAVIX 82 78 54 46
BUSPIRONE HCL 81 59 55 151
MICARDIS 80 72 56 332
SPIRONOLACTONE 80 48 56 73
ZETIA 79 79 58 71
SUBOXONE 78 0 59 297
FINASTERIDE 76 71 60 110
AZOR 76 76 60 262
NIFEDIPINE ER 76 74 60 81
AZITHROMYCIN 70 52 63 44
JANUVIA 70 62 63 68
AMITRIPTYLINE HCL 68 62 R 65 70
ISOSORBIDE MONONITRATE ER 67 47 66 60
LACTULOSE 67 67 66 192
LYRICA 65 58 68 91
GLIPIZIDE 64 40 69 53
MECLIZINE HCL 63 47 70 101
KLOR-CON M20 63 34 70 51
PROMETHAZINE HCL 62 38 R 72 77
LEVEMIR 59 55 73 161
HUMALOG 58 51 74 196
TRAZODONE HCL 56 52 75 47
LEVOFLOXACIN 56 49 75 79
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 40 77 107
METHOTREXATE 53 37 77 195
LIPITOR 52 51 79 76
DIOVAN HCT 52 48 79 59
HYDRALAZINE HCL 52 44 79 48
SINGULAIR 51 35 82 83
MORPHINE SULFATE ER 50 38 S2 83 173
SPIRIVA 50 40 83 75
QUETIAPINE FUMARATE 50 35 83 78
PREMARIN 50 39 R 83 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.